- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Oncology Care Model: Additional Concerns
Bruce Feinberg, DO; Scott Gottlieb, MD; Brian Kiss, MD; and Ted Okon, MBA, continue to discuss the Oncology Care Model established by the CMS and how it is likely to affect physicians and their practices.
Dr Kiss explains why his organization opted not to participate in the Oncology Care Model, but rather to collaborate with healthcare systems independently.
The Oncology Care Model will impact the physician’s choice to see and care for Medicare patients, projects Dr Gottlieb. Additionally, he remarks, the new model is likely to further affect community practices and result in consolidation because of its complex structure and burden on physicians.
Because the model includes a vast number of performance-based measures, and because these measures are constantly changing, physicians don’t understand how they are being measured, explains Mr Okon. To describe the effect of this issue, he compares a physician who attempts to work under the new model with an athlete who tries to play golf blindfolded.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
